In case you missed it: Feb. 14 to Feb. 18

It was a busy week for the Contemporary OB/GYN® team.

This week's top articles included:

Cardiologist confirmed to head FDA

Robert Califf was approved in a 50-46 vote by the senate.

Read more

Price transparency in hospitals remains elusive, in spite of rule

Just 14.3% of hospitals complying with rule meant to encourage consumer price shopping.

Read more

Postmenopausal vulvovaginal discomfort

Postmenopausal vaginal symptom severity is not significantly linked to vaginal microbiota or mucosal inflammatory markers, according to a small study in the American Journal of Gynecology & Obstetrics.

Read more

Risk of rheumatoid arthritis with endometriosis

Patients with endometriosis are nearly four times as likely to develop rheumatoid arthritis (RA) than those without endometriosis, according to a study in the Journal of Women’s Health.

Learn more

Oral ibrexafungerp for treating acute VVC

Patients with acute vulvovaginal candidiasis (VVC) greatly benefited from oral ibrexafungerp (Brexafemme, Scynexis), according to results of a global phase 3 randomized, double-blind, placebo-controlled superiority study published in the international journal of obstetrics and gynecology, BJOG.

Read more

Impact of dual burden differs by insurance type

Risk factors for the dual burden of severe maternal morbidity and preterm birth differ significantly by insurance type across sociodemographic and perinatal considerations in the state of California, according to a study in the Maternal and Children Health Journal.

Read more